Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 1, 2015 |
| Target | Kythera Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Allergan |
| Deal Type | Add-on Acquisition |
| Deal Value | 2.1B USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1948 |
| Sector | Life Science |
| Employees | 11,400 |
Allergan, Inc. is a pharmaceutical company. Allergan's products include ophthalmic pharmaceuticals, dermatology products, and neurological products.
| Deal Context for Buyer | # |
|---|---|
| Overall | 14 of 14 |
| Sector: Life Science | 5 of 5 |
| Type: Add-on Acquisition | 13 of 13 |
| State: California | 8 of 8 |
| Country: United States | 14 of 14 |
| Year: 2015 | 3 of 3 |
| Size (of disclosed) | 2 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-08-31 |
Naurex
Evanston, Illinois, United States Naurex, Inc. is a clinical-stage biopharmaceutical company developing transformative therapies for challenging disorders of the central nervous system. |
Buy | $560M |